Literature DB >> 2493835

Management of bleeding varices in the elderly.

S W Hosking1, N C Bird, A G Johnson, D R Triger.   

Abstract

In 207 consecutive patients the outcome of bleeding varices was compared in those aged under 65 (n = 146) and those aged over 65 (n = 61). All patients were seen during seven years and were treated by active initial and maintenance sclerotherapy. Alcoholic cirrhosis was commoner in younger patients (68 (47%) v 12 (20%] and cryptogenic cirrhosis commoner in older patients (21 (34%) v 19 (13%]. Mortality due to the first bleed was dependent on the severity of liver disease and was unrelated to age. Survival corrected for age (life table analysis) was 65% at one year and 60% at two years for both groups of patients. It is concluded that patients should not be denied active treatment for bleeding varices on the basis of age alone. In order to obtain optimum results early endoscopy and sclerotherapy is essential.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493835      PMCID: PMC1835488          DOI: 10.1136/bmj.298.6667.152

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  1 in total

1.  Injection sclerotherapy for oesophageal varices in the elderly.

Authors:  C M Roberts; B Carey; R Faizallah; R J Walker; N Krasner; A I Morris; S N Marcus
Journal:  Age Ageing       Date:  1983-05       Impact factor: 10.668

  1 in total
  4 in total

1.  Bleeding varices in the elderly.

Authors:  D R Triger
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

Review 2.  General surgery.

Authors:  I Taylor
Journal:  Postgrad Med J       Date:  1990-05       Impact factor: 2.401

3.  Lower gastrointestinal bleeding in the elderly.

Authors:  Maxwell M Chait
Journal:  World J Gastrointest Endosc       Date:  2010-05-16

4.  Endoscopic injection sclerotherapy for esophageal varices in the elderly.

Authors:  M Ohta; M Hashizume; T Kamakura; K Ueno; M Tomikawa; K Tanoue; S Kitano; K Sugimachi
Journal:  World J Surg       Date:  1994 Sep-Oct       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.